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Abstract: In this study, monensin (MON) was investigated for its apoptotic and genotoxic effects on chick liver tissue and cytotoxic and
apoptotic effects on chick primary hepatocytes isolated from perfused liver tissue. Western blotting and real-time PCR (qPCR) were
used to determine the apoptotic effect on primary hepatocytes and liver tissue, and the comet assay was used to determine the genotoxic
effect on liver tissue. MON decreased cell viability in primary hepatocytes with increasing concentrations. When administered at
concentrations of 1 and 10 µM, MON increased the levels of apoptotic p53, caspase-3, and caspase-9, and downregulated the expression
of the antiapoptotic survivin, Bcl-xl, and Bcl-2 genes (p < 0.05). Furthermore, 100 and 125 ppm of MON increased caspase-3, caspase-9,
and p53 protein levels, and downregulated Bcl-2 expression (p < 0.05). Bcl-xl gene expression was downregulated only in the group that
received 125 ppm of MON (p < 0.05). Changes observed in the expression of the survivin gene were insignificant in both groups (p >
0.05). Moreover, 100 and 125 ppm of MON caused comet formation, which is a marker of genotoxicity, in the liver (p < 0.05). Our results
indicate that MON induced apoptosis in both primary hepatocytes and liver tissue, and also caused genotoxicity in the liver tissue.
Key words: Monensin, apoptosis, chick, hepatocyte, liver

1. Introduction
The incorporation of anticoccidial drugs in feed for the
prevention or prophylaxis of coccidiosis is a common
practice in the modern poultry industry. The use of
anticoccidial drugs in broiler chickens ranges from 70%
to 98% in the United States, compared to 91% in Western
Europe. Anticoccidial drugs are also widely used in other
major poultry production regions across the world [1].
Monensin (MON) is a monovalent carboxylic polyether
ionophore antibiotic produced by fungi belonging to
the species Streptomyces cinnamonensis [2]. MON, the
molecular formula of which is C36H62O11, is considered a
sodium ionophore as its affinity for the sodium ion (Na+)
is considerably higher compared to other ions [3,4]. MON
is used as a feed additive for the control of coccidiosis in
quails, chickens, turkeys, and goats; to improve growth
and feed efficiency in beef cattle; and to minimize body
condition losses, increase milk protein, and reduce milk
fat in dairy cattle. In addition, controlled-release capsules
are available for the prevention of subclinical ketosis in
dairy cattle [5]. Although MON is considered a safe drug
when used at therapeutic doses, it is toxic when overdosed.
Owing to its narrow therapeutic index, MON is likened to
a two-edged knife. Its effects on metal ions form the basis
of its toxic/harmful effects on animals [6]. MON facilitates
Na+ ion influx into the cell in both hosts and parasites. An

increased intracellular Na+ ion concentration stimulates
Na+/Ca++ exchange, leading to an increased intracellular
concentration of extracellular Ca++ ions [7]. Excessively
increased Na+ and Ca++ ions cause cytotoxicity through pH
change, calcium overload, catecholamine release and lipid
peroxidation in the cell [8].
Previous studies have shown that MON causes damage
to tissues and organs, in particular to the heart and skeletal
muscles, by changing the biochemical, hematological
and lipid peroxidation parameters [9–12]. To date, no in
vivo study has been conducted on the effects of MON on
apoptosis and genotoxicity. Furthermore, in vitro studies
are limited to several types of cancer cells, and there is no
study on the effects of MON on primary hepatocytes [13–
18]. In this study, we aimed to investigate the in vivo and
in vitro apoptotic effects of MON, which is widely used in
the poultry industry, on the chick liver.
2. Materials and methods
2.1. Reagents and chemicals
Monensin sodium, penicillin, streptomycin, fetal bovine
serum, L-glutamine, Dulbecco’s modified eagle medium
(DMEM), ethylene diamine tetra-acetic acid (EDTA),
Tris-base, milk powder, LMA, HMA, NaCl, NaOH,
N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic
acid
(HEPES), and ethidium bromide were purchased from
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Sigma (USA). Magnesium chloride was supplied from
Carlo Erba Reagents (Spain). Hank’s balanced salt
solution (HBSS) was purchased from Santa Cruz (USA).
Collagenase II, protease and phosphatase inhibitor
cocktail, RIPA buffer, SuperSignal West Pico PLUS
chemiluminescent substrate, and Pierce BCA Protein
Assay Kit were purchased from Thermo Scientific (USA).
Ethanol, dimethyl sulfoxide (DMSO) and Triton X-100
were supplied from Merck (Germany). RNAzol was
supplied from the Molecular Research Centre (USA).
EvoScript Universal cDNA Master and LightCycler
480 Probes Master Kit were purchased from Roche
(Switzerland). Polyvinylidene fluoride (PDVF) membrane
was purchased from Bio-Rad (USA). p53, anticaspase-3,
and anticaspase-9 were purchased from Abcam (USA).
Antirabbit and antibeta actin antibody were supplied from
Cell Signaling (USA). All other chemicals and reagents
were analytical grade.
2.2. Animals
In this study, one-day-old Leghorn layer chicks were used.
All chicks were commercially obtained at one day of age.
The chicks were provided with ad libitum commercial
chicken feed and water for 60 days, and were randomly
assigned to 3 groups with 15 animals in each group.
In addition, five animals that received drug-free and
additive-free feed were divided for in vitro study. MON is
used for the prevention of coccidiosis chickens reared for
laying up to a maximum of 16 weeks of age. Therefore, the
application period was determined as 60 days in order to
demonstrate the toxicity of MON in less than 16 weeks.
The minimum and maximum doses accepted as safe by the
European Food Safety Authority [19] were administered
to the trial groups. While the control group received
drug- and additive-free feed, the other two groups were
administered with 100 ppm of MON (Coxidin 200,
Huvepharma) and 125 ppm of MON in feed for 60 days.
At the end of the trial period, the animals were sacrificed
and their liver tissue was extracted. Liver tissue samples
were freshly studied on the day of extraction for the comet
assay. On the other hand, liver tissue samples transferred
to cryotubes were shock-frozen in a nitrogen tank at –196
ºC, and stored at –80 ºC until being used for Western
blot and real-time PCR analyses. The in vivo study was
carried out in accordance with the directive of the Animal
Experiments Ethics Committee of Erciyes University
(Approval Date and No: 16.11.2016 and 16/138).
2.3. Chick hepatocyte isolation and primary cell culture
The two-stage collagenase perfusion technique, first
developed by Berry and Friend [20] and later modified
by Seglen [21], was used for the isolation of chicken
hepatocytes. Preoperatively, the abdominal and breast
feathers of the chickens (60–65 days old) were shaved and
a 10% povidone-iodine solution was used for asepsis. After

526

the abdominal cavity of the chicken, anesthetized by the
inhalation of 2.5% sevoflurane (Abbvie, 4456), was opened,
a 26G IV catheter was inserted into the portal vein. Firstly,
perfusion buffer-I (at 37 °C and a 10 mL/min flow rate),
containing 0.9 mM MgCl2, 0.5 mM EDTA and 25 mM
HEPES and HBSS (without Ca+2 and Mg+2), and secondly,
perfusion buffer-II (at 37 °C and a 25 mL/min flow rate),
containing 1000 U collagenase II, was infused into the
portal vein. The caudal vena cava was cut with a scalpel
to allow the perfusion buffer out of the vein. Perfusion
continued until the color of the liver turned pale. Primary
hepatocytes were isolated in a laminar flow cabinet
(SafeFast Elite), from the liver, which was extracted under
sterile conditions postperfusion. A Cedex-XS (Innovatis)
device was used for hepatocyte cell counts. Primary
hepatocytes were cultured in DMEM supplemented
with penicillin (100 IU/mL), 10% fetal bovine serum,
streptomycin (100 mg/mL), and L-glutamine (2 mM) in
an incubator (New Brunswick Galaxy 170R) containing a
moisturised atmosphere of 5% CO2 at 37 °C.
2.4. MTS cytotoxicity test
The MTS assay was used to determine cell viability and
cytotoxicity. Primary hepatocytes were planted in a 96well cell culture plate at an intensity of 1 × 104 cells /well
and incubated at 37 °C for 24 h. Afterwards, the cells were
applied with different concentrations (1, 2, 4, 5, 10, 20,
and 40 µM) of MON at 37 °C for 24 h. MTS reagent was
added to each well and incubated for 1 h. At the end of
the incubation period, the optical density of the formazan
crystals was measured on a microplate reader (BioTek
Synergy H1) at a wavelength of 490 nm. The viability of the
untreated control cells was accepted as 100%. The viability
of the cells in the other groups was expressed as percentage
(%) compared to the control cells.
2.5. Gene expression analysis
Primary hepatocytes were planted into six-well plates at
an intensity of 2 × 106 cells /well and incubated at 37 °C
for 24 h. Hepatocytes treated with 1 and 10 µM of MON
were incubated at 37 °C for 24 h, then the cells were
harvested with a scraper for RNA isolation. RNAzol was
used for RNA isolation from the hepatocytes and liver
tissue, EvoScript Universal cDNA Master was used for
cDNA synthesis, and a LightCycler 480 Probes Master Kit
was used for real-time polymerase chain reaction (qPCR)
analysis. Roche’s LightCycler Nano was used to determine
the expression of the antiapoptotic survivin, Bcl-xl, and
Bcl-2 and genes. CT values were measured and calculated
using the 2-ΔΔCT formula. Values were normalized with
beta-actin. The genes are shown in Table 1.
2.6. Western blot analysis
Western blot analysis was performed as described by
Towbin et al. [22]. Primary hepatocytes, planted into
six-well cell culture plates (2 × 106 cells per well), were
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Table 1. Probe catalogue number and sequences of primers used for real-time PCR analysis.
Gene

Right primer

Left primer

Probe catalogue no

Survivin

ggtggagacgaggtagacca

aaaatggcggcctatgct

04688040001

Beta-actin

acgagcgcagcaatatcat

gctctgactgaccgcgtta

04688996001

Bcl-xl

gagctgcgtggtggatgt

aagtgaccccatggttgtgt

04688066001

Bcl-2

actatctcgcggttgtcgtag

cttcccctcggaaaccat

04685059001

incubated for 24 h. Hepatocytes treated with 1 and 10 µM
of MON were harvested with a scraper for protein isolation
after 24 h of incubation. While RIPA buffer supplemented
with phosphatase and protease inhibitor cocktail was used
for protein isolation from the hepatocytes and liver tissue,
a Pierce BCA Protein Assay Kit was used for quantitation.
Proteins were mixed with the loading buffer (40 µg), boiled
at 95 °C for 5 min, subjected to 5%–10% SDS-PAGE, and
transferred onto a PVDF membrane (Bio-Rad, USA). The
membranes were blocked with 5% milk powder in TBST
buffer at RT for 1 h and were incubated overnight at +4 °C
on a shaker with primary antibodies, including antibeta
actin (1:500; Cell Signaling), anticaspase-3 (1:1000;
Abcam), anticaspase-9 (1:1000; Abcam), and anti-p53
(1:1000; Abcam). After the membranes were incubated
with secondary antirabbit antibody (1:5000; Cell Signaling)
in the dark for 2 h, the bands were visualized using the
Super Signal West Pico Plus chemiluminescence imaging
reagent on the Bio-Rad ChemiDoc Imaging System. The
intensity of each band was measured densitometrically
with the ImageJ software and changes were calculated in
comparison to the control and MON after normalization
with β-actin.
2.7. Alkaline comet assay
The alkaline comet assay developed by Tice et al. [23] was
used to determine the genotoxic effect of MON on liver
tissue. Fresh liver tissue was minced with cold mincing
buffer (20 mM EDTA, 10% DMSO, and HBSS, pH 7.5) to
obtain a single-cell suspension. Samples were centrifuged
at 1000 g for 15 min and then resuspended in cold mincing
buffer. The cell suspension mixed with 0.5% LMA was
embedded onto microscope slides previously precoated
with a layer of 1.6% HMA. Slides were immersed in
cold alkaline lysis solution for 1 h (10 mM Tris-base,
1% Triton X-100, 100 mM EDTA, 2.5 M NaCl, and 10%
DMSO, pH: 10). The slides were placed inside a horizontal
electrophoretic tank in cold electrophoresis buffer (200
mM EDTA, and 10 N NaOH, pH: 13) for 20 min to ensure
DNA unwinding, and then electrophoresed at 25 V and
300 mA for 20 min. Next, the slides were immersed in
neutralization buffer (400 mM Trizma pH 7.5) 3 times
for 5 min, then dehydrated with ice-cold methanol and
dried at room temperature. Subsequently, the slides were

stained with 20 g/mL of ethidium bromide, visualized
under a fluorescent microscope (Leica-microsystems),
and quantified using the Comet image analysis software
(Comet Assay IV, Perspective Instruments). Randomly
selected 100 cells per sample were analyzed to determine
DNA damage.
2.8. Statistical analysis
The IBM SPSS Statistics 21 package program was used
for the statistical evaluation of data. Data were expressed
as mean ± standard deviation. While MTS and comet
assay data were analyzed by one-way ANOVA, Tamhane’s
and Tukey’s tests were used to determine the differences
between the groups. Western blot and qPCR data were
evaluated by the one-sample t-test. p < 0.05 were regarded
as statistically significant.
3. Results
3.1. In vitro results
3.1.1. Effect of MON on cell viability
Treatment with 2 μM and higher concentrations (4, 5,
10, 20, and 40 μM) of MON significantly decreased the
viability of primary hepatocytes, when compared to the
control group (p < 0.05). On the other hand, treatment
with 1 μM of MON also decreased cell viability, but this
change was statistically insignificant (p > 0.05) (Figure 1).
3.1.2. Effect of MON on apoptotic proteins
While the group treated with 1 μM of MON showed
significantly increased (p < 0.05) caspase-3 (36 kDa),
caspase-9 (19 kDa), and p53 levels (3.35-, 2.16-, and 2.98fold, respectively) compared to the control group, the
increase in the caspase-3 (18 kDa) and caspase-9 (46 kDa)
levels (1.06- and 1.16-fold, respectively) was statistically
insignificant (p > 0.05). On the other hand, in the group
treated with 10 μM of MON, caspase-3 (18 kDa and 36
kDa), caspase-9 (19 kDa and 46 kDa), and p53 levels were
determined to have significantly increased (2.10-, 1.68-,
3.22-, 2.41-, and 1.88-fold, respectively), in comparison to
the control group (p < 0.05) (Figure 2).
3.1.3. Effect of MON on antiapoptotic genes
When compared to the control group, the expression of
the survivin, Bcl-xl, and Bcl-2 genes was found to have
been downregulated in the groups treated with 1 μM of
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Figure 1. MTS assay to measure cell viability and cytotoxicity
of hepatocytes. The values were stated as the mean ± standard
deviation (n = 12). Differences according to control were
considered statistically significant when *p < 0.05.

MON (0.29-, 0.36-, and 0.27-fold, respectively) and 10
μM of MON (0.30-, 0.45-, and 0.37-fold, respectively) (p
< 0.05) (Figure 3).
3.2. In vivo results
3.2.1. Effect of MON on apoptotic proteins
Compared to the control group, the group treated with 100
ppm of MON displayed significantly increased caspase-3
(18 kDa and 36 kDa), caspase-9 (19 kDa and 46 kDa),

and p53 levels (1.79-, 1.45-, 2.12-, 2.22-, and 2.63-fold,
respectively) (p < 0.05). In the group given 125 ppm of
MON, when compared to the control group, the caspase-3
(36 kDa), caspase-9 (19 kDa), and p53 levels (2.07-, 7.58, and 3.92-fold, respectively) were determined to have
significantly increased (p < 0.05), whilst the increase in the
caspase-3 (18 kDa) and caspase-9 (46 kDa) levels (1.14and 1.25-fold respectively) was statistically insignificant (p
> 0.05). (Figure 4).
3.2.2. Effect of MON on antiapoptotic genes
In comparison to the control group, the expression of the
Bcl-2 gene was downregulated in the groups that received
100 ppm (0.50-fold) and 125 ppm (0.39-fold) of MON (p
< 0.05). The expression of Bcl-xl was found to have been
downregulated (0.30-fold) in only the group that received
125 ppm of MON (p < 0.05). While the expression of the
survivin gene was downregulated (0.87-fold) in the group
that received 100 ppm of MON and upregulated (1.75fold) in the group that received 125 ppm of MON, when
compared to the control group, these alterations were
statistically insignificant (p > 0.05) (Figure 5).
3.2.3. Effect of MON on genotoxicity
Compared to the control group, there was a significant
decrease in the comet head intensity, and a significant
increase in the comet tail intensity in the groups that received
100 ppm and 125 ppm of MON (p < 0.05) (Figure 6).

Figure 2. Protein levels of caspase-3, caspase-9, and p53 in hepatocytes were measured by Western blotting analysis. β-Actin
was used as a loading control. The values were stated as the mean ± standard deviation (n = 3). Differences according to control
were considered statistically significant when *p < 0.05.

1
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1

1

Figure 3. The gene expression levels of Bcl-2, Bcl-xl, and survivin in hepatocytes were measured by real-time PCR (qPCR)
analysis. β-Actin was used as a housekeeping gene. The values were stated as the mean ± standard deviation (n = 3).
Differences according to control were considered statistically significant when *p < 0.05.

Figure 4. Protein levels of caspase-3, caspase-9, and p53 in liver tissue were measured by Western blotting analysis. β-Actin
was used as a loading control. The values were stated as the mean ± standard deviation (n = 3). Differences according to
control were considered statistically significant when *p < 0.05.
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Figure 5. The gene expression levels of Bcl-2, Bcl-xl, and survivin in hepatocytes were measured by real-time PCR (qPCR)
analysis. β-Actin was used as a housekeeping gene. The values were stated as the mean ± standard deviation (n = 3).
Differences according to control were considered statistically significant when *p < 0.05.

1

Figure 6. The alkaline comet assay was used to determine the
genotoxic effect of MON on liver tissue. The values were stated as
the mean ± standard deviation. Differences according to control
were considered statistically significant when *p < 0.05.

4. Discussion
MON is frequently used for the prevention and treatment
of coccidiosis, which is an important problem in poultry
breeding [5]. Although MON is considered a safe drug
when administered in therapeutic doses, it is toxic in case
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of overdose [6, 24–26]. MON increases intracellular Ca++
concentration, leading to intracellular ROS production
and Ca++ dependent apoptosis [7, 27–29]. While it has been
reported that the main target organs for MON are the heart
and skeletal muscles, there are studies that have proven the
toxic effects of the drug on the liver. These studies have
shown that MON causes a dose-dependent reduction in
hepatic weight in chickens together with biochemical and
histopathological changes in the liver [8–12, 30].
In the in vitro part of the study, the cytotoxic effect of 1
and 10 μM of MON on primary hepatocytes was evaluated.
Although there is no previous study investigating the
effects of MON on primary hepatocytes, there are several
studies on the effects of MON on cell proliferation and
death in different types of cancer cells. In these studies, it
has been shown that increasing concentrations of MON
decrease cell viability over time [13–18]. Similarly, our
study has shown that MON decreases cell viability with
increasing concentrations.
One and 10 μM of MON induced apoptosis by causing
an increase in caspase-3, caspase-9, and p53 levels and a
downregulation in Bcl-2, Bcl-xl, and survivin expressions
in hepatocytes. Although the underlying mechanism
of apoptosis varies, our data showed that apoptosis was
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induced via the mitochondrial pathway. It is known that
p53 shows antioxidant activity under low oxidative stress
conditions, and causes cell death by exhibiting prooxidative
activity under high oxidative stress conditions [31]. In
addition, MON is reported to cause lipid peroxidation by
increasing intracellular calcium levels [32]. Accordingly,
in the present study, the increase in hepatocyte p53 levels
was attributed to MON-induced oxidative stress. It has
been reported that Bcl-2 and Bcl-xl bind to proapoptotic
proteins and prevent loss in the mitochondrial membrane
potential, cytochrome c release, and thus, apoptosis [33].
In our study, it is suggested that increased p53 levels
cause the release of proapoptotic proteins by suppressing
antiapoptotic Bcl-2, Bcl-xl and survivin, and thus increase
the permeability of the outer mitochondrial membrane.
Cytochrome c is released from the mitochondria
into the cytosol due to the loss of the mitochondrial
membrane potential and triggers apoptosome formation,
which activates caspase-9. Caspase-9 activates effector
procaspases, including procaspase-3, and thereby, initiates
the process of apoptosis. In addition, decreased levels of
survivin, which is a caspase inhibitor, can increase the
levels of caspase-3 and -9 by avoiding inhibition [34, 35].
In the light of this information, in the present study, it
was assumed that the downregulation of Bcl-xl, and Bcl-2
expression activated caspase-3 and caspase-9, and likewise,
increased p53 levels increased caspase-3 and caspase-9
levels by downregulating the expression of survivin and
preventing the inhibition of caspases. Although there is
no previous study investigating the effects of MON on
chicken hepatocytes, researches have been conducted on
cancer cell lines. In these studies, it was determined that,
in cells treated with different concentrations of MON, the
level of the antiapoptotic protein Bcl-2 decreased, whilst
the levels of the apoptotic proteins caspase-3 and caspase-9
increased [14–18]. In a previous study on the toxic effects
of salinomycin, another ionophore antibiotic, it was
reported that while the expression of apoptotic caspase-3
and caspase-9 was upregulated, that of antiapoptotic BCL2 was downregulated in primary chicken cardiomyocytes
[36]. Similar data was obtained in the present study.
Coxidin 200 microGranulate consists of 25%
monensin sodium, 15%–20% perlite and 55%–60%
wheat bran [19]. Perlite, an amorphous alumina-silicate,
is commercially available as HARBORLITE. Perlite is
used as a filler agent in Coxidin formulation1. Limited
data indicate that the LD50 (oral intake) of perlite in
rats is greater than 10 g/kg. No toxic effects associated

with perlite have been reported in animals [37]. Wheat
bran is a source of insoluble fiber [38]. Wheat bran is
used as a diluent agent in Coxidin formulation2. It was
reported that wheat bran supplementation could increase
nutrient digestibility in broilers [39]. Therefore, although
a commercial product of MON was used for the in vivo
experiments, additional ingredients could be ignored to
evaluate effects on MON. In the in vivo part of the study,
both doses of MON were ascertained to have triggered
apoptosis by increasing apoptotic protein levels and
downregulating the expression of antiapoptotic genes. It
is known that MON induces oxidative stress by increasing
the intracellular calcium concentration, and p53 causes
cell death by exhibiting prooxidative activity under severe
oxidative damage conditions [31, 32]. In addition, it is
suggested that oxidative stress-induced DNA damage,
which may occur upon exposure to MON, activates p53,
which increases the permeability of the mitochondrial
membrane, eventually facilitating the release of
cytochrome c from the mitochondria into the cytosol by
binding to antiapoptotic Bcl-xl, and Bcl-2. Cytochrome c
triggers apoptosome formation, which activates caspase-9.
Caspase-9 activates effector procaspases, including
procaspase 3, and triggers the apoptosis process [34, 40].
In the present study, the increase observed in p53 levels
with the administration of both MON concentrations
could be a result of oxidative DNA damage induced
by MON. Furthermore, it is estimated that increased
p53 levels cause a downregulation in Bcl-xl, and Bcl-2
expression and an increase in caspase-3 and caspase-9
levels, thus inducing apoptosis via the mitochondrial
pathway. Although there is no previous study on the
apoptotic effects of MON in chickens, this subject has
been investigated in mice. Park et al. [15] observed that
MON increased p53 levels and decreased Bcl-2 levels in
mice with experimentally induced tumors. Similar data
was obtained in the present study.
Intracellular ROS, produced mostly in the
mitochondria, can target structures, which are susceptible
to oxidative damage, such as the DNA [41, 42]. Although
DNA is a stable and well-preserved molecule, ROS can
interact with it and cause various damages such as the
modification of DNA bases, DNA-protein crosslinking,
single and double DNA breaks, and damage to the DNA
repair system [43]. DNA damage impairs respiratory
chain functions by disrupting the RNA transcription of
proteins involved in the electron transport chain, and also
further increases ROS production, resulting in the loss of

Agnew KEM, Benikos CP, Hewitt WA, Key EJ, Lloyd JM (2018). Monensin water dispersible granules by wet granulation. U.S. Patent No. 10,117,849.
Washington, DC: U.S. Patent and Trademark Office [online]. Website https://patents.justia.com/patent/10117849/ [accessed 18.02.2022].
1

CRL Feed Additives Authorisation (2005). Evaluation Report of the Community Reference Laboratory Feed Additives Authorisation on the Method(s)
of Analysis for Coxidin® (Dossier No. FAD-2005-0003) [online]. Website https://joint-research-centre.ec.europa.eu/publications/fad-2005-0003_en/
[accessed 18.02.2022].
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the mitochondrial membrane potential and impaired ATP
synthesis. All these events result in apoptosis mediated by
the mitochondrial pathway [41]. Based on the results of
the comet assay, it is suggested that both 100 and 125 ppm
of MON cause DNA damage in the liver by either directly
reacting with DNA or possibly inducing free radical
generation. The previous studies on the DNA-damaging
effects of MON are limited. There is evidence that MON
or similar drugs induce DNA damage in other species.
In a study, it was reported that MON could induce DNA
damage in earthworm coelomocytes (Eisenia fetida) by
causing comet formation [44]. In addition, another study
it was shown that MON induces DNA fragmentation in
rat testis tissue [45]. In another study, it was observed
that salinomycin, another ionophore antibiotic, caused
DNA damage in chicken lymphocytes by increasing the
tail length of the comet [46]. Our study is in line with the
results of previous studies.
5. Conclusion
MON, which has indications for use in various animal
species and is described as a double-edged blade, is
considered a safe drug at therapeutic doses. However, in
this study, liver damage characterized by apoptosis and
genetic damage was observed even upon the administration
of therapeutic doses. Therefore, it is important to use
MON in combination with other anticoccidial drugs (e.g.,
nicarbazin) at low doses and for limited time periods to
ensure the protection of animal and consumer health.

Although it is considered that the hepatotoxic effects
of MON may be caused by free radicals, further more
detailed studies are required for the demonstration of the
highly complex and multifactorial toxic effect mechanisms
of this drug.
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